These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 25257194

  • 21. Red blood cell transfusion in patients with anti-Yta.
    Wong SM, Cawthorne T, Dennington PM, Hong FS.
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [Abstract] [Full Text] [Related]

  • 22. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H, Brand A.
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [Abstract] [Full Text] [Related]

  • 23. Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.
    Santos B, Portugal R, Nogueira C, Loureiro M.
    Transfusion; 2015 Jun; 55(6 Pt 2):1394-8. PubMed ID: 25677578
    [Abstract] [Full Text] [Related]

  • 24. Hyperhemolysis Syndrome without Underlying Hematologic Disease.
    Eberly LA, Osman D, Collins NP.
    Case Rep Hematol; 2015 Jun; 2015():180526. PubMed ID: 25785210
    [Abstract] [Full Text] [Related]

  • 25. Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E.
    Yasuda H, Ohto H, Yamaguchi O, Sakuma S, Suzuki T, Mita M, Tsuneyama H, Uchikawa M.
    Transfus Sci; 2000 Oct; 23(2):107-12. PubMed ID: 11035271
    [Abstract] [Full Text] [Related]

  • 26. Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Fuja C, Kothary V, Carll TC, Singh S, Mansfield P, Wool GD.
    Transfusion; 2022 Jul; 62(7):1446-1451. PubMed ID: 35588309
    [Abstract] [Full Text] [Related]

  • 27. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease.
    Reyes MA, Illoh OC.
    Immunohematology; 2008 Jul; 24(2):45-51. PubMed ID: 19852130
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population.
    Matsuno T, Matsuura H, Fujii S, Suzuki R, Sugiura Y, Miura Y.
    Int J Hematol; 2022 Mar; 115(3):440-445. PubMed ID: 34714525
    [Abstract] [Full Text] [Related]

  • 30. Anti-Kpa-induced severe delayed hemolytic transfusion reaction.
    Koshy R, Patel B, Harrison JS.
    Immunohematology; 2009 Mar; 25(2):44-7. PubMed ID: 19927619
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Management of hemolytic transfusion reactions.
    Hendrickson JE, Fasano RM.
    Hematology Am Soc Hematol Educ Program; 2021 Dec 10; 2021(1):704-709. PubMed ID: 34889404
    [Abstract] [Full Text] [Related]

  • 33. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS, Boyd JS, Parwani AV, Tanz WS, Ness PM, King KE.
    Transfusion; 2002 Nov 10; 42(11):1435-41. PubMed ID: 12421216
    [Abstract] [Full Text] [Related]

  • 34. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y, Wu Y, Yang Y, Chen B, Li J, Guo G, Xiong F.
    Front Immunol; 2021 Nov 10; 12():698541. PubMed ID: 35003054
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z, Duffett L, Tokessy M, Cote J, Goldman M, Saidenberg E.
    Transfusion; 2012 Jul 10; 52(7):1476-81. PubMed ID: 22233405
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transfusion-related red blood cell alloantibodies: induction and consequences.
    Tormey CA, Hendrickson JE.
    Blood; 2019 Apr 25; 133(17):1821-1830. PubMed ID: 30808636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.